NICE public health guidance update

被引:2
作者
Ali, Fizzah [1 ]
Gabbay, Mark [2 ]
Baillie, Nick [3 ]
机构
[1] NICE, London SW1A 2BU, England
[2] Univ Liverpool, Gen Practice, Liverpool L69 3BX, Merseyside, England
[3] NICE, Leadership & Engagement, London SW1A 2BU, England
关键词
LOW-BACK-PAIN; SICKNESS CERTIFICATION; GRADED ACTIVITY; REHABILITATION; PATIENT; TRIAL;
D O I
10.1093/pubmed/fdaa112
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This article highlights recent guidance from the National Institute for Health and Care Excellence (NICE). It highlights the organization's response to the COVID-19 pandemic and then provides a spotlight on workplace health in the context of long-term sickness absence and capability to work. It discusses some of the actions that need to be taken by a range of stakeholders in order to implement NICE guidance in this area and aid employees in ensuring good workplace health. The NICE guidance on workplace health, discussed in this article, predates the current pandemic. Comment is made specifically on fitness for work assessments, where the COVID-19 pandemic has posed a range of unique clinical challenges.
引用
收藏
页码:E100 / E102
页数:3
相关论文
共 50 条
  • [1] Ivabradine in heart failure: NICE guidance
    Hardman, Suzanna M. C.
    [J]. HEART, 2014, 100 (02) : 93 - 95
  • [2] NICE Guidance, But Who Does the Work?
    Peel, D. N. Y.
    [J]. CLINICAL ONCOLOGY, 2011, 23 (01) : 1 - 3
  • [3] The influence of NICE guidance on the uptake of laparoscopic surgery for colorectal cancer
    Green, Chris J.
    Maxwell, Roy
    Verne, Julia
    Martin, Richard M.
    Blazeby, Jane M.
    [J]. JOURNAL OF PUBLIC HEALTH, 2009, 31 (04) : 541 - 545
  • [4] NICE guidance on cabozantinib for previously treated advanced renal cell carcinoma
    Elsada, Ahmed
    Adler, Amanda I.
    [J]. LANCET ONCOLOGY, 2017, 18 (09) : 1153 - 1154
  • [5] Public consultation changes guidance on the use of health-care interventions. An observational study
    Campbell, Bruce
    Tabiri-Essuman, Jeffrey
    Gallo, Helen
    Verdiel, Vassilia
    Mandava, Lakshmi
    Azhar, Mohamed Ansaf
    Powell, John
    [J]. HEALTH EXPECTATIONS, 2017, 20 (02) : 361 - 368
  • [6] NICE guidance on bortezomib and thalidomide for first-line treatment of multiple myeloma
    Doss, Sally
    Hay, Nicola
    Sutcliffe, Frances
    [J]. LANCET ONCOLOGY, 2011, 12 (09) : 837 - 838
  • [7] Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: NICE guidance
    Ahmad, Yousif
    Lip, Gregory Y. H.
    [J]. HEART, 2012, 98 (19) : 1404 - 1406
  • [8] Public Engagement and Neurology: An Update
    Lavorgna, Luigi
    Brigo, Francesco
    Esposito, Sabrina
    Abbadessa, Gianmarco
    Sparaco, Maddalena
    Lanzillo, Roberta
    Moccia, Marcello
    Inglese, Matilde
    Bonfanti, Luca
    Trojsi, Francesca
    Spina, Emanuele
    Russo, Antonio
    De Micco, Pasquale
    Clerico, Marinella
    Tedeschi, Gioacchino
    Bonavita, Simona
    [J]. BRAIN SCIENCES, 2021, 11 (04)
  • [9] Public health guidance to facilitate timely diagnosis of dementia: ALzheimer's COoperative Valuation in Europe recommendations
    Brooker, Dawn
    La Fontaine, Jenny
    Evans, Simon
    Bray, Jennifer
    Saad, Karim
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2014, 29 (07) : 682 - 693
  • [10] International Consensus Guidance for Management of Myasthenia Gravis 2020 Update
    Narayanaswami, Pushpa
    Sanders, Donald B.
    Wolfe, Gil
    Benatar, Michael
    Cea, Gabriel
    Evoli, Amelia
    Gilhus, Nils Erik
    Illa, Isabel
    Kuntz, Nancy L.
    Massey, Janice
    Melms, Arthur
    Murai, Hiroyuki
    Nicolle, Michael
    Palace, Jacqueline
    Richman, David
    Verschuuren, Jan
    [J]. NEUROLOGY, 2021, 96 (03) : 114 - 122